SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as its community rallies around token burns tied to watcher milestones, fueling excitement and perceived scarcity. Talk centers on the strong community, the potential for significant upside, and a desire to reach number one on trending lists. The coin is built on the Solana network and the community is anticipating airdrop details.

Aventus

Aventus ($AVT.X) is trending amid community excitement, with many highlighting its low market cap and potential for significant gains, especially as it's listed on Coinbase. Discussions revolve around breaking resistance levels and the possibility of a new exchange listing acting as a catalyst. Some users also point to its underlying technology and partnerships as reasons for its potential.

Brewski

$BREWSKI.X is trending as users celebrate 'American spirit' and brotherhood, frequently pairing it with meme-related coins. The community is highlighting potential whale activity and positioning it as the 'next great American runner'. Conversations also suggest a potential connection to current political trends.

Pump.fun

$PUMP.X is trending as traders discuss its potential, recent website updates, and community takeover of creator rewards, driving bullish sentiment. Conversations revolve around potential breakout points, with community members calling for it to reach penny status. The coin is associated with the meme coin launchpad Pump.fun on the Solana network.

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending as community members highlight its strong ties to the Injective ecosystem and anticipate significant gains. The conversation is driven by Injective's increasing traction and potential ETF, with many believing $NONJA.X offers leveraged exposure to $INJ's growth. Community members emphasize $NONJA.X's unique features, such as its strong community, burned liquidity, and potential for high returns.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor ($NVTS) is trending amid community discussions around a potential breakout and anticipation for news related to its partnership with Nvidia ($NVDA). Some traders speculate about a possible acquisition, while others are focused on insider trading activity and the impact of the new CEO, Chris Allexandre, on the company's future direction in AI data centers.

Nobody Sausage is a unique online presence that embodies the playful, humorous side of internet culture. Created by Kael Cabral, this character has evolved into a beloved brand that resonates with people through its quirky personality and entertaining content.  Impact and Significance 1. Community building: Nobody Sausage has fostered a sense of community among its fans, who share and engage with its content, creating a collective experience. 2. Entertainment value: The character's quirky personality and humor provide endless entertainment for online audiences, making it a go-to destination for laughs and good times. 3. Cultural relevance: Nobody Sausage has become a symbol of the absurd, joyful aspects of internet culture, reflecting the ever-changing nature of online trends and memes.

Nobody Sausage

Nobody Sausage ($NOBODY.X) is trending as the community rallies behind it, aiming for substantial gains. Social media的热点似乎是其低市值和近期价格走势，投资者正密切关注其动量，一些人将其与之前的成功案例相比较。The focus is on potentially significant returns, similar to those seen with other recent coins.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is trending as investors digest mixed signals, including commentary around tariffs and a potential shift towards energy project ownership. Community members are actively debating the impact of government policies and comparing CSIQ's valuation to peers. Bullish sentiment highlights the company's potential in a growing solar market, while bears express concern over debt and profitability.

bichi

BICHI.X is trending amid claims of substantial gains and community calls for coordinated buying to drive the price higher. Discussions highlight the token's low market cap and potential for significant returns, with some comparing it to other meme coins that have experienced rapid growth. The community is actively encouraging others to invest, referencing prior successes with similar tokens.

A memecoin.  Memecoin is exactly what it sounds like—a memecoin called memecoin. In a world dominated by meme-driven hype and community spirit, it only makes sense to have a token that embodies the entire memecoin movement. Launched on PEPE’s birthday, memecoin aims to represent the absurdity, humor, and heart of the memecoin economy. It’s here to bring hope, laughter, and a bit of chaos—while never pretending to be more than it is: just a memecoin. And maybe that’s exactly what we need.

Memecoin

Memecoin is trending as the community discusses potential weekend runs and targets, drawing comparisons to previous coins with significant gains. Traders are actively monitoring its low market cap and increasing volume, speculating about a possible surge. The coin's connection to the 9gag platform is also being highlighted as a potential driver for growth and adoption.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?

ETFs to Capitalize on the Novo Nordisk-Septerna Deal

Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk

Danish drug maker Novo Nordisk (NVO) on Tuesday announced an exclusive global collaboration and license agreement with U.S.-based Septerna, Inc. (SEPN) to discover, develop, and commercialise oral small-molecule medicines for obesity, type 2 diabetes, and other cardiometabolic diseases.The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916006">said</a> the deal could be worth up to $2.2 billion. This includes more than $200 million in upfront and near-term milestone payments to Septerna and additional research, development, and commercial milestone payments.The California-based company is also eligible to receive tiered royalties on global net sales of marketed products.Novo Nordisk will cover all research and development expenses for partnered programs under the collaboration.The agreement is expected to close in the second quarter of 2025.The companies will initially commence four development programmes for potential small-molecule therapies directed at select G-protein-coupled receptor (GPCR) targets. GPCRs are a large and diverse family of cell membrane proteins involved in cellular communication.Septerna CEO Jeffrey Finer said that the collaboration provides an opportunity to create multiple oral medicines and provides the company with the operational flexibility and resources to advance its portfolio of other GPCR-targeted programmes.On Stocktwits, retail sentiment around Novo Nordisk fell from ‘bullish’ to ‘bearish’ territory over the past 24 hours while message volume dropped from ‘extremely high’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:629/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_14_at_8_28_57_AM_png_13db4d5cfd.webp" alt="Screenshot 2025-05-14 at 8.28.57 AM.png" width="629" height="64"><figcaption>NVO's Sentiment Meter and Message Volume as of 8:30 a.m. ET on May 14, 2025 | Source: Stocktwits</figcaption></figure> Meanwhile, retail sentiment on Septerna jumped from ‘bearish’ to ‘extremely bullish’ territory while message volume jumped from ‘normal’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:628/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_14_at_8_31_56_AM_png_a149898af9.webp" alt="Screenshot 2025-05-14 at 8.31.56 AM.png" width="628" height="62"><figcaption>SEPN's Sentiment Meter and Message Volume as of 8:35 a.m. ET on May 14, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expressed concerns about the new agreement, opining that Septerna’s pipeline is in the “early stage.”<stembedurl>https://stocktwits.com/NEVER_SAY_TRANSITORY/message/614571231</stembedurl>However, another investor expressed optimism on the stock if it breaks the $12.40 mark.<stembedurl>https://stocktwits.com/Trad3Slinger/message/614572114</stembedurl><a href="https://stocktwits.com/symbol/SEPN">SEPN stock</a> is up by about 70% in premarket trading on Wednesday.The stock is down by 68% this year and nearly 69% over the past 12 months.<a href="https://stocktwits.com/symbol/NVO">NVO stock</a>, meanwhile, is trading nearly 3% higher in pre-market.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nvidia-backed-databricks-acquires-database-startup-neon/chiqpslRbNL">Nvidia, Microsoft-Backed Databricks Bets Big On AI Agents With $1B Neon Takeover: Retail Turns Extremely Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Novo Nordisk logo is displayed on a smartphone with stock market percentages in the background. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)

Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled

Septerna CEO Jeffrey Finer said that the collaboration allows the company to create multiple oral medicines and provides the operational flexibility and resources to advance its portfolio of other GPCR-targeted programmes.

Equity

Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones

Analysts initiated coverage on Septerna, Inc. with Overweight ratings and price targets of $50 and $38. SEPN's innovative platform and potential pipeline make it a promising biopharma player.
read...

Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.

SEPN
Septerna Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SEPN News

SEPN Septerna Inc.